CompoAtlas

Enercor Film Coated Tablet

Enercor Film Coated Tablet : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

No point flagged by the rules applied to recognised ingredients.

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Magnesium AscorbateMagnesium Ascorbate[230;mg;1012;mg]Vitamine C
Calcium AscorbateCalcium Ascorbate[209;mg;1012;mg]Vitamine C
L-Carnitine L-tartrateL-Carnitine L-tartrate[117.7;mg;1012;mg]L-Carnitine L-Tartrate
TaurineTaurine[100;mg;1012;mg]Taurine
Vitamin E (d-alpha tocopherol)Vitamin E (d-alpha tocopherol)[30.4;mg;1012;mg]Vitamine E
Calcium D-pantothenateCalcium D-pantothenate[23.9;mg;1012;mg]Acide pantothénique (vitamine B5)
NiacinamideNiacinamide[10.6;mg;1012;mg]Nicotinamide (vitamine B3)
COENZYME Q10COENZYME Q10[10;mg;1012;mg]Ubiquinone
THIAMINE MONONITRATETHIAMINE MONONITRATE[9.77;mg;1012;mg]Vitamine B1 (thiamine)
RIBOFLAVINERIBOFLAVINE[7.9;mg;1012;mg]Vitamine B2 (riboflavine)
BiotinBiotin[7.2;mg;1012;mg]Biotine (vitamine B8)
NiacinNiacin[5.3;mg;1012;mg]Not identified
Pyridoxine HClPyridoxine HCl[2.56;mg;1012;mg]Vitamine B6
CyanocobalaminCyanocobalamin[0.39;mg;1012;mg]Vitamine B12

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
MAL06100589XC
Type
Health supplement
Published status
PRODUCT APPROVED
Licence holder
WONG`S NATURE CURE CENTRE
Manufacturer
VITA TECH INTERNATIONAL
Importer
WONG`S NATURE CURE CENTRE
Registration period starting
2026-10-22
Published validity end
2031-10-22

Original register data

View published fields and their variants
Active ingredients
Magnesium Ascorbate[230;mg;1012;mg],Calcium Ascorbate[209;mg;1012;mg],L-Carnitine L-tartrate[117.7;mg;1012;mg],Taurine[100;mg;1012;mg],Vitamin E (d-alpha tocopherol)[30.4;mg;1012;mg],Calcium D-pantothenate[23.9;mg;1012;mg],Niacinamide[10.6;mg;1012;mg],COENZYME Q10[10;mg;1012;mg],THIAMINE MONONITRATE[9.77;mg;1012;mg],RIBOFLAVINE[7.9;mg;1012;mg],Biotin[7.2;mg;1012;mg],Niacin[5.3;mg;1012;mg],Pyridoxine HCl[2.56;mg;1012;mg],Cyanocobalamin[0.39;mg;1012;mg]
Valid until
2031-10-22
Registration date
2026-10-22
Published description
HEALTH SUPPLEMENT
Licence holder
WONG`S NATURE CURE CENTRE
Importer
WONG`S NATURE CURE CENTRE
Producer
VITA TECH INTERNATIONAL
Published name
Enercor Film Coated Tablet
Published reference
2004081582559
Registration number
MAL06100589XC
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL06100589XC

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Taurine
    Read the warning, when it applies and the studies cited

    TAURINE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Lopez Ramon et al. 2007; Seghieri et al. 2007).

    Sources cited by Health Canada (2)
    • López Ramón Y Cajal C, Ocampo Martínez R, Couceiro Naveira E, Martínez M. Amino acids in amniotic fluid in the 15th-16th weeks of gestation and preterm labor. The Journal of Maternal-Fetal & Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 2007;20(3):225-231.
    • Seghieri G, Tesi F, Bianchi L, Loizzo A, Saccomanni G, Ghirlanda G, Anichini R, Franconi F. Taurine in women with a history of gestational diabetes. Diabetes Research and Clinical Practice 2007;76(2):187-192. PubMed

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 30 January 2026

  • COENZYME Q10
    Read the warning, when it applies and the studies cited

    Coenzyme Q10 (UBIQUINONE-10)

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood pressure medication (Rosenfeldt et al. 2007; Singh et al. 1999).

    Sources cited by Health Canada (2)
    • Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong JY, Watts GF. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. Journal of Human Hypertension 2007;21(4):297-306. PubMed Meta-analysis
    • Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. Journal of Human Hypertension 1999;13(3):203-208. PubMed Randomised trial

    Applies to products providing more than 100 mg of Coenzyme Q10 per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Engelsen et al. 2003; Landbo and Almdal 1998; Spigset 1994).

    Sources cited by Health Canada (3)
    • Engelsen J, Nielsen JD, Hansen KF. [Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial]. Ugeskr Laeger 2003;165(18):1868-1871 (in Danish). PubMed Randomised trial
    • Landbo C, Almdal TP. [Interaction between warfarin and coenzyme Q10]. Ugeskr Laeger 1998;160(22):3226-3227 (in Danish). PubMed Case report
    • Spigset O. Reduced effect of warfarin caused by ubidecarenone. Lancet 1994;344(8933):1372-1373. PubMed Case report

    Condition of application: Migraine prophylaxis/prevention.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if migraine frequency increases and associated nausea and vomiting persist or worsen.

    Health Canada monograph dated 31 January 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Enercor Film Coated Tablet”, https://compoatlas.com/en/supplements/malaysia/MAL06100589XC-enercor-film-coated-tablet, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line